BofA analyst Peter Galbo lowered the firm’s price target on Procter & Gamble to $174 from $180 and keeps a Buy rating on the shares. Among the firm’s consumer staples coverage, BofA is “cutting estimates for topline and EPS almost universally” for Q3 with a few exceptions, the analyst tells investors in a preview for the packaged food, beverages, HPC and tobacco groups.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $176 from $180 at UBS
- Walmart Stock (WMT) Feeling the Love of the Crowd Once Again
- Procter & Gamble price target lowered to $153 from $164 at Barclays
- 3 ‘Boring’ Stocks Analysts Say Could Quietly Outperform Google Stock
- Procter & Gamble recommends stockholders reject mini-tender by Tutanota